维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Alter ML"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Early urinary and plas- ma biomarkers for experimental diabetic nephropathy 显示文摘	Alter ML Kretschmer A Van Websky K	2012	Clin Lab2012，58，78：	1
2	Renal and cardiac effects of DPP -4 inhibitors from preclinical development to clinical research 显示文摘	Hocher B Reichetzeder C Alter ML	2012	Kidney Blood Pressure Res2012，36，1：	1
3	Par- vovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples显示文摘	Yu MY Alter HJ Virata-Theimer ML	2010	Transfusion2010，50，8：	1
4	DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy显示文摘	Alter ML Ott IM von Websky K	2012	Kidney Blood Press Res2012，36，1：	1
5	Early urinary and plas- ma biomarkers for expreimental diabetic nephropathy 显示文摘	Alter ML Kretschmer A Von Websky K	2012	Clin Lab2012，58，78：	1
6	Altering the association properties of insulin by amino acid replacement显示文摘	Brems DN Alter LA Beckage ML	1992	Protein Eng1992，5，6：	1
7	Early Urinary and Plasma Biomarkers for Experimental Diabetic Nephropathy 显示文摘	Alter ML Kretschrner A Von Websky K	2012	Clinical Laboratory2012，58，7：	1
8	Renal and cardiac effects of DPP4 inhibitors-- from preelinical development to clinical research显示文摘	Hocher B Reichetzeder C Alter ML	2012	Kidney Blood Press Res2012，36，1：	1
9	Parvovirus B19 in-fection transmitted by transfusion of red blood cells confirmed bymolecular analysis of linked donor and recipient samples显示文摘	Yu MY Alter HJ Virata-Theimer ML	2010	Transfusion2010，50，8：	1
10	Renal and cardiac effects of DPP-4 inhibitors - from preclinical development to clinical research 显示文摘	Hocher B Reichetzeder C Alter ML	2012	Kidney Blood Press Res2012，36，1：	1
11	Early urinary and plasma biomarkers for experimental diabetic nephropathy显示文摘	Alter ML Kretschmer A Von Websky K	2012	Clin Lah2012，58，78：	1
12	DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach fordiabetic nephropathy显示文摘	Alter ML Ott IM von Websky K	2012	Kidney Blood Press Res2012，36，1：	1
13	DPP-4 inhibitor on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy 显示文摘	Alter ML Ott 1M Websky K	2012	Kidney Blood Press Res2012，，：	1
14	Early urinary and plasma biomarkers for experimental diabetic nephrepathy 显示文摘	Alter ML Kretschmer A Von Websky K	2012	Clin Lab2012，58，78：	1
15	Renal and cardiac effects of DPP-4 inhibitors-from preclinical development to clinical research显示文摘	Hocher B Reichetzeder C Alter ML		0，，01：	1
16	Early urinary and plasma biomarkers for experimental diabetic nephropathy显示文摘	Alter ML Kretschmer A Von Websky K	2012	Clin Lab2012，58，78：	1
17	DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy 显示文摘	Alter ML Ott IM yon Websky K et a l	2012	Kidney Blood Press Res2012，36，1：	1
18	DPP-4 Inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy显示文摘	Alter ML Ott IM yon Websky K	2012	Kidney Blood Press Res2012，36，：	1
19	Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies显示文摘	Yu B Liu W Yu WM Loh ML Alter S Guvench O	2013	Mol Cancer Ther2013，12，9：	1
20	DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeuticapproach for diabetic nephropathy 显示文摘	Alter ML Ott IM Von Websky	2012	Kidney Blood Press Res2012，36，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示